查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418350

生物製藥輔料市場報告：2030 年趨勢、預測與競爭分析

Biopharmaceuticals Excipients Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物製藥輔料的趨勢與預測

預計到 2030 年，全球生物製藥輔料市場將達到 40 億美元，2024 年至 2030 年複合年成長率為 5.6%。該市場的主要驅動力是擴大採用多功能輔料以及製藥公司對非專利市場的日益關注。全球生物製藥輔料市場的未來前景廣闊，增溶劑/界面活性劑/乳化劑、多元醇和碳水化合物市場充滿機會。

生物製藥輔料市場洞察

Lucintel 預測，由於對蛋白質療法的需求增加，碳水化合物在預測期內仍將是最大的細分市場。

由於對生物製藥製造的高需求，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到2030年，全球生物製藥輔料市場預計將達到40億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球生物製藥輔料市場預計將以5.6%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是多功能輔料的日益採用以及製藥公司對非專利市場的日益關注。

Q4.市場的主要細分市場是什麼？

A4. 生物製藥輔料市場前景廣闊，增溶劑/界面活性劑/乳化劑、多元醇和碳水化合物市場充滿機會。

Q5.市場上主要企業有哪些？

A5. 生物製藥輔料的主要企業如下。

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於對蛋白質治療藥物的需求增加，碳水化合物在預測期內仍將是最大的細分市場。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 在預測期內，北美將繼續成為最大的地區，因為對生物製藥製造的需求很高。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球生物製藥輔料市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物製藥輔料市場趨勢（2018-2023）與預測（2024-2030）
  • 全球生物製藥輔料市場（按產品）
    • 增溶劑和界面活性劑/乳化劑
    • 多元醇
    • 碳水化合物

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球生物製藥輔料市場區域分佈
  • 北美生物製藥輔料市場
  • 歐洲生物製藥輔料市場
  • 亞太生物製藥輔料市場
  • 其他地區生物藥輔料市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球生物製藥輔料市場成長機會（按產品）
    • 全球生物製藥輔料市場成長機會（按地區）
  • 全球生物製藥輔料市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物製藥輔料市場的產能
    • 全球生物製藥輔料市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant
簡介目錄

Biopharmaceuticals Exicipents Trends and Forecast

The future of the global biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets. The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

A more than 150-page report is developed to help in your business decisions.

Biopharmaceuticals Exicipents by Segment

The study includes a forecast for the global biopharmaceuticals exicipents by products and region.

Biopharmaceuticals Exicipents Market by Products [Shipment Analysis by Value from 2018 to 2030]:

  • Solubilizes & Surfactants/Emulsifiers
  • Polyols
  • Carbohydrates

Biopharmaceuticals Exicipents Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biopharmaceuticals Exicipents Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopharmaceuticals exicipents companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceuticals exicipents companies profiled in this report include-

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Biopharmaceuticals Exicipents Market Insights

Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Features of the Global Biopharmaceuticals Exicipents Market

Market Size Estimates: Biopharmaceuticals exicipents market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopharmaceuticals exicipents market size by products, region, and region in terms of value ($B).

Regional Analysis: Biopharmaceuticals exicipents market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the biopharmaceuticals exicipents market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceuticals exicipents market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biopharmaceuticals exicipents market size?

Answer: The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030.

Q2. What is the growth forecast for biopharmaceuticals exicipents market?

Answer: The global biopharmaceuticals exicipents market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biopharmaceuticals exicipents market?

Answer: The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

Q4. What are the major segments for biopharmaceuticals exicipents market?

Answer: The future of the biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets.

Q5. Who are the key biopharmaceuticals exicipents market companies?

Answer: Some of the key biopharmaceuticals exicipents companies are as follows.

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6. Which biopharmaceuticals exicipents market segment will be the largest in future?

Answer: Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

Q7. In biopharmaceuticals exicipents market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceuticals exicipents market by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopharmaceuticals Exicipents Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biopharmaceuticals Exicipents Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biopharmaceuticals Exicipents Market by Products
    • 3.3.1: Solubilizes & Surfactants/Emulsifiers
    • 3.3.2: Polyols
    • 3.3.3: Carbohydrates

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biopharmaceuticals Exicipents Market by Region
  • 4.2: North American Biopharmaceuticals Exicipents Market
  • 4.3: European Biopharmaceuticals Exicipents Market
    • 4.3.1: European Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.4: APAC Biopharmaceuticals Exicipents Market
    • 4.4.1: APAC Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.5: ROW Biopharmaceuticals Exicipents Market
    • 4.5.1: ROW Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Products
    • 6.1.2: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Region
  • 6.2: Emerging Trends in the Global Biopharmaceuticals Exicipents Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biopharmaceuticals Exicipents Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceuticals Exicipents Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Colorcon
  • 7.3: BASF
  • 7.4: Associated British Foods
  • 7.5: Signet Excipients
  • 7.6: Sigachi Industries
  • 7.7: Spectrum Chemical Manufacturing
  • 7.8: Roquette Freres
  • 7.9: IMCD
  • 7.10: Clariant